Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-27

FDA Approved: PRAZIQUANTEL — Original Application (Endo USA, Inc.)

View source ↗

Summary

The FDA approved Endo USA, Inc.'s original application for praziquantel, enabling a generic version of the antihelminthic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Praziquantel (Praziquantel)

Snippet

ORIG AP for PRAZIQUANTEL (PRAZIQUANTEL)